SAEM: A Serious Game for Emotional Regulation Problems in Adolescents (SAEMGame)

November 29, 2021 updated by: Juan Miguel Flujas, Universidad de Almeria

A Serious Game for Psychological Assessment and Intervention in Adolescents With Emotional Regulation Problems

This study aims to assess the effects of an intervention to improve emotional regulation skills in adolescents with affective (anxiety and/or depression) and behavioral problems.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

Emotional regulation skills and strategies are a protective factor against various problems and psychopathologies. The development and maintenance of affective symptoms are usually very harmful to the adolescent and for his/her family and social environment and can lead to other more serious psychological problems (depression, anxiety, adaptive disorders, etc.) or problems of socio-educational maladjustment.

This study aims to improve the emotional regulation of adolescents who present affective symptoms related to anxiety, depression, or behavioral problems, such as difficulties in their interpersonal relationships, impulsivity, anxiety, anger attacks, low tolerance to frustration, apathy, or sadness. The intervention program, applied through a video game, is an intervention protocol for emotional well-being that has been tested and validated in an adolescent population with emotional and behavioral problems.

Study Type

Interventional

Enrollment (Anticipated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Inmaculada Gómez-Becerra, Prof.
  • Phone Number: +34 950 214414
  • Email: igomez@ual.es

Study Contact Backup

Study Locations

    • Andalucia
      • Almeria, Andalucia, Spain, 04009
        • Torrecárdenas Hospital
      • Almería, Andalucia, Spain, 04120
        • University of Almeria
    • Castellón
      • Castellón De La Plana, Castellón, Spain, 12071
        • University Jaume I

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 12 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Between 12 and 16 years old
  • Show affective symptoms associated with depression and anxiety or behavior problems
  • Show willingness to participate in the research study
  • Understand written and spoken Spanish
  • Show stability in treatment dosage, if taking medication.

Exclusion Criteria:

  • Exhibit incapacitating neurological and/or intellectual impairment
  • Have a diagnosis of severe mental disorder
  • Substance abuse addiction or dependence

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: eHealth Emotion Regulation Skills
The intervention aims to develop competencies for emotional regulation through exposure and acceptance strategies for coping with circumstances that produce stress or emotional discomfort. The application has a series of mini-games that the user will overcome throughout a narrative, with different challenges and rewards
This intervention aims to aim to develop competencies for emotional regulation through exposure and acceptance strategies. This intervention is applied through a serious game developed for this purpose. the adolescent will complete a series of missions aimed at developing skills related to psychological flexibility, namely, greater psychological acceptance, mindfulness in the present moment, and committed actions in the direction of personal values. This serious game is guided by a therapist.
Other Names:
  • Isla de SAEM (Salud Emocional) (ES)
No Intervention: Waiting List
He or she will not be exposed to the intervention but will remain on the waiting list and will complete the pre and post-measures.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Difficulties in Emotional Regulation Scale (DERS; Hervás & Jódar, 2008)
Time Frame: Change from baseline at immediately after the intervention, and at 3 months
Consists of 28 items that make up 6 dimensions of emotional dysregulation: attention, acceptance, impulsivity, clarity, goals and strategies. The reliability index is between .87 and .93.
Change from baseline at immediately after the intervention, and at 3 months
Revised Child Anxiety and Depression Scale (RCADS-30; Pineda et al., 2018)
Time Frame: Change from baseline at immediately after the intervention, and at 3 months
it is a 30-item scale to assess the presence of symptoms associated or compatible with depression and anxiety in children and adolescents. Internal consistency between .78 and .93.
Change from baseline at immediately after the intervention, and at 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Avoidance and Fusion Questionnaire for Young People (AFQ-Y; Valdivia-Salas, Martín-Albo, Zaldívar, Lombas, & Jiménez, 2016)
Time Frame: Change from baseline at immediately after the intervention, and at 3 months
that assesses the level of avoidance and cognitive fusion present when faced with distressing situations. This scale presents a Cronbach's alpha between .76 and 87.
Change from baseline at immediately after the intervention, and at 3 months
. Willingness and Action Scale for Children and Adolescents (WAM; Cobos, Flujas-Contreras, & Gomez, 2020)
Time Frame: Change from baseline at immediately after the intervention, and at 3 months
) to assess levels of acceptance and behavioral activation (action) in the direction of valued life areas. This scale shows an internal consistency between .76 and .81.
Change from baseline at immediately after the intervention, and at 3 months
Mood and coping
Time Frame: Change from baseline at immediately after the intervention, and at 3 months
At the start and close of the App, a series of questions will appear that measure mood of the users by means of a visual face scale (5-point Likert) and a coping question by means of a 5-point Likert scale.
Change from baseline at immediately after the intervention, and at 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Inmaculada Gómez Becerra, Prof PhD, Universidad de Almeria

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

January 1, 2022

Primary Completion (Anticipated)

July 30, 2022

Study Completion (Anticipated)

December 30, 2022

Study Registration Dates

First Submitted

November 29, 2021

First Submitted That Met QC Criteria

November 29, 2021

First Posted (Actual)

December 13, 2021

Study Record Updates

Last Update Posted (Actual)

December 13, 2021

Last Update Submitted That Met QC Criteria

November 29, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • UALPsy002

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

The data will be published in a data repository and in the publications that are necessary. The data related to the responses will be published in the self-reported evaluation systems, mainly, pre, post and follow-up that have an impact on the evaluation of the effectiveness of the treatment.

IPD Sharing Time Frame

At the end of the RCT. For a period of 1 year.

IPD Sharing Access Criteria

Open access in data repository or under request to authors.

IPD Sharing Supporting Information Type

  • Study Protocol
  • Informed Consent Form (ICF)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adolescents

Clinical Trials on Serious Game: Emotional Health Island (SAEM)

Subscribe